Clinical Medical Officer - Pain Therapeutic Biotech

About the Company

• A well-funded, innovation-driven Biotech with global development ambitions is seeking an experienced Head of Clinical Development to lead the clinical strategy and execution of its non-oncology pipeline, with a strong preference for candidates possessing expertise in Neurology, Pain Management, or related therapeutic areas.
• This is a senior leadership position with broad strategic influence across global clinical development, regulatory interactions, portfolio decision-making, and team leadership.

About the Job

• Define and execute global clinical development strategies for innovative non-oncology assets.
• Lead the design, conduct, and interpretation of Phase I–III clinical studies.
• Oversee clinical development plans, timelines, budgets, and risk mitigation activities.
• Drive key development milestones from early clinical stages through registration.
• Lead medical and clinical components of IND and NDA submissions in China and the United States.
• Serve as the primary clinical representative in interactions with regulatory authorities, including FDA and CDE/NMPA.
• Provide strategic leadership for major regulatory meetings such as Pre-IND, End-of-Phase 2, and Pre-NDA discussions.
• Assess clinical, scientific, and commercial opportunities across the development portfolio.
• Participate in asset prioritization and Go/No-Go decision-making processes.
• Support due diligence efforts for external licensing and business development opportunities.
• Build and maintain relationships with leading Key Opinion Leaders (KOLs) and academic experts.
• Provide insights into unmet medical needs and emerging scientific trends.
• Lead product-level medical strategy and cross-functional scientific communications.

Required Qualifications

• MD degree required; specialization in Neurology, Pain Medicine, Internal Medicine, Anesthesiology, or related fields highly preferred.
• 10+ years of pharmaceutical clinical development experience.
• Proven track record leading innovative non-oncology drug development programs through late-stage clinical development and regulatory submission.
• Direct leadership experience in at least one Phase III program and successful NDA submission in China.
• Experience supporting or leading simultaneous China-US IND filings.
• Exposure to both small-molecule and biologic development programs.
• Strong background in Neurology and/or Pain indications is highly desirable.
• Demonstrated success leading and growing multidisciplinary clinical organizations.
• Experience managing teams of 10+ professionals.
• Entrepreneurial mindset with the ability to build teams, processes, and capabilities from the ground up.
• Strong understanding of FDA, NMPA, and ICH guidelines.
• Experience participating directly in regulatory authority interactions.
• Fluent English communication skills required.
• Ability to independently author and review key clinical and regulatory documents.

Why This Opportunity?

• Key leadership role with significant influence on corporate and portfolio strategy.
• Opportunity to work on differentiated innovative assets addressing high unmet medical needs.
• Exposure to global development and regulatory pathways.
• Dynamic, entrepreneurial environment with strong executive support and growth potential.